Buscar
IRadimed Corp
IRMDAñadir a la lista de seguimiento
100.970USD
+2.930+2.99%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
1.29BCap. mercado
54.48P/E TTM
Más Datos de IRadimed Corp Compañía
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Información de IRadimed Corp
Símbolo de cotizaciónIRMD
Nombre de la empresaIRadimed Corp
Fecha de salida a bolsaJul 16, 2014
Director ejecutivoSusi (Roger)
Número de empleados160
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 16
Dirección12705 Ingenuity Drive
CiudadORLANDO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32826
Teléfono14076778022
Sitio Webhttps://www.iradimed.com/
Símbolo de cotizaciónIRMD
Fecha de salida a bolsaJul 16, 2014
Director ejecutivoSusi (Roger)
Ejecutivos de IRadimed Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Joe Kiani
Mr. Joe Kiani
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de IRadimed Corp?
Los cinco principales accionistas de IRadimed Corp son: Mr. James B. (Jim) Hawkins
¿Cuántas instituciones poseen acciones de IRadimed Corp (IRMD)?
A fecha de 2026Q1, 407 instituciones poseen acciones de IRadimed Corp, con un valor de mercado combinado de aproximadamente 8.32M, lo que representa el 65.08% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -453182.00.
¿Cuál es la mayor fuente de ganancias de IRadimed Corp?
El 2026Q1, el segmento empresarial MRI Compatible IV Infusion Pump Systems generó la ganancia más alta para IRadimed Corp, ascendiendo a 31.64M y representando el 37.75% de la ganancia total.